Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Els C. van der Wiel"'
Autor:
Harm A.W.M. Tiddens, Hettie M. Janssens, Els C. van der Wiel, Aukje C. Bos, Ilaria Meneghelli, Sonia Volpi, Beatrice Guidetti, Menno M. van der Eerden
Publikováno v:
Paediatric cystic fibrosis (CF).
Autor:
Harry G.M. Heijerman, Menno M. van der Eerden, Christof J. Majoor, Eleni-Rosalina Andrinopoulou, Hubertus G.M. Arets, Els C. van der Wiel, Harm A.W.M. Tiddens, Mehdi Albasri, Jennifer J. Meerburg
Publikováno v:
Pediatric Pulmonology, 54(11), 1794. Wiley-Liss Inc.
Pediatric Pulmonology. Wiley-Liss Inc.
Pediatric pulmonology, 54(11), 1794-1800. Wiley-Liss Inc.
Pediatric Pulmonology
Pediatric Pulmonology. Wiley-Liss Inc.
Pediatric pulmonology, 54(11), 1794-1800. Wiley-Liss Inc.
Pediatric Pulmonology
Background Many cystic fibrosis (CF) patients chronically infected with Pseudomonas aeruginosa are on maintenance tobramycin inhalation therapy. Cough is reported as a side effect of tobramycin inhalation powder (TIP) in 48% of the patients. Objectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63583a847cfb3b2dfe321294a913ec7c
https://dspace.library.uu.nl/handle/1874/391887
https://dspace.library.uu.nl/handle/1874/391887
Autor:
Marianne Nuijsink, Bert Arets, Daan J Touw, Els C. van der Wiel-Kooij, Erik M. van Maarseveen, Bas Pullens, Gijsbert A. van Zanten, Hettie M. Janssens, Harry G.M. Heijerman, J.W.F. Uges, Annelies J van Velzen
Publikováno v:
British Journal of Clinical Pharmacology, 85(9), 1984-1993. Wiley
British Journal of Clinical Pharmacology
British Journal of Clinical Pharmacology. Wiley-Blackwell Publishing Ltd
British Journal of Clinical Pharmacology, 85(9), 1984. Wiley-Blackwell
British Journal of Clinical Pharmacology
British Journal of Clinical Pharmacology. Wiley-Blackwell Publishing Ltd
British Journal of Clinical Pharmacology, 85(9), 1984. Wiley-Blackwell
Aims: We aimed to compare the pharmacokinetics (PK) and safety profile of tobramycin inhalation solution (TIS) using the I-neb device to the standard PARI-LC Plus nebulizer in children with cystic fibrosis. Methods: A randomized, open-label, crossove
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c4098d085c7fa5ba8dc2f40b630a84d
https://dspace.library.uu.nl/handle/1874/392026
https://dspace.library.uu.nl/handle/1874/392026
Autor:
Alexandra L. Quittner, Leonie A. Tepper, Elisabeth M. W. J. Utens, Els C. van der Wiel, Daan Caudri, Harm A.W.M. Tiddens
Publikováno v:
Pediatric Pulmonology. 49:1182-1189
Summary Introduction Cystic fibrosis (CF) lung disease is characterized by bronchiectasis and trapped air on chest computed tomography (CT). Objective We aim to validate bronchiectasis and trapped air as outcome measures by evaluating associations be
Autor:
E. Marije Bakker, Harm A.W.M. Tiddens, Daan Caudri, Gerard J. J. M. Borsboom, Mph Margaret Rosenfeld Md, Els C. van der Wiel-Kooij
Publikováno v:
Pediatric Pulmonology. 48:1081-1088
Background In young children with cystic fibrosis (CF) the forced expiratory volume in 1 second (FEV1) is often normal and a more sensitive measure to detect early obstructive lung disease is needed. Aim To evaluate the progression of selected spirom
Autor:
Leonie A, Tepper, Daan, Caudri, Elisabeth M W J, Utens, Els C, van der Wiel, Alexandra L, Quittner, Harm A W M, Tiddens
Publikováno v:
Pediatric pulmonology. 49(12)
Cystic fibrosis (CF) lung disease is characterized by bronchiectasis and trapped air on chest computed tomography (CT).We aim to validate bronchiectasis and trapped air as outcome measures by evaluating associations between changes in bronchiectasis,
Autor:
Aukje C. Bos, Els C. van der Wiel, Karla Gonzalez-Graniel, Leonie A. Tepper, Harm A.W.M. Tiddens, Hugo J. Duivenvoorden, Elisabeth M. W. J. Utens, Alexandra L. Quittner, Daan Caudri
Publikováno v:
European Respiratory Journal, 42, 371-379. European Respiratory Society
European respiratory journal, 42(2), 371-379. European Respiratory Society
European respiratory journal, 42(2), 371-379. European Respiratory Society
Cystic fibrosis (CF) is primarily characterised by bronchiectasis and trapped air on chest computed tomography (CT). The revised Cystic Fibrosis Questionnaire respiratory symptoms scale (CFQ-R RSS) measures health-related quality of life. To validate
Autor:
Harm A.W.M. Tiddens, Els C. van der Wiel-Kooij, Wim C. J. Hop, Bernhard Müllinger, Philipp Kroneberg, E. Marije Bakker
Publikováno v:
Journal of Allergy and Clinical Immunology, 132(2), 482-485. Mosby Inc.
Autor:
Carmelo Gabriele, Els C. van der Wiel, Henriëtte A. Moll, Johan C. de Jongste, Eveline M. Nieuwhof, Peter J. F. M. Merkus
Publikováno v:
Pediatric Allergy and Immunology, 18, 1, pp. 36-41
Pediatric Allergy and Immunology, 18, 36-41
Pediatric Allergy and Immunology, 18, 36-41. Blackwell Publishing
Pediatric Allergy and Immunology, 18, 36-41
Pediatric Allergy and Immunology, 18, 36-41. Blackwell Publishing
Contains fulltext : 53621.pdf (Publisher’s version ) (Closed access) Guidelines for the measurement of fractional exhaled nitric oxide (FE(NO)) recommend refraining from lung function tests (LFT) and certain foods and beverages before performing FE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ad26f239b6e934de4339a5ab981a45a
https://hdl.handle.net/2066/53621
https://hdl.handle.net/2066/53621
Autor:
Ward Hofhuis, Johan C. de Jongste, Els C. van der Wiel, Wim P.J. Holland, Harm A.W.M. Tiddens, Peter J.F.M. Merkus
Publikováno v:
Pediatric pulmonology. 40(5)
Airway malacia is present in a small proportion of wheezing infants. The usefulness of infant lung-function testing (ILFT) in ruling out malacia in wheezy infants is unknown. We assessed the predictive value of ILFT parameters for airway malacia diag